BioNeMo
NVIDIA's framework for training and deploying biomolecular foundation models — provides pre-trained models for protein language embeddings, molecular generation, and structure prediction, accessible via cloud API or local deployment.
What it does
BioNeMo is NVIDIA’s platform for biomolecular AI, providing pre-trained foundation models and a framework for fine-tuning them on specific tasks. Rather than training a model from scratch — which requires large datasets and significant compute — BioNeMo lets researchers start from models already trained on large biomolecular corpora and adapt them to their specific problem.
Core pre-trained models available through BioNeMo include:
- ESM-2 — a protein language model that generates embeddings (numerical representations) of protein sequences; useful as a starting point for property prediction or downstream analysis
- MolMIM — a molecular generation model for small-molecule drug design
- DiffDock — a diffusion model for protein-ligand docking (predicting how a drug molecule binds to a protein)
- AlphaFold2 integration — structure prediction accessible within the platform
BioNeMo is available both as a cloud-hosted API (NVIDIA AI) and as an open framework (BioNeMo Framework on GitHub) for groups with their own GPU infrastructure.
Best for
Research groups with GPU resources who want to fine-tune biomolecular foundation models on their own datasets without building the training infrastructure from scratch. Particularly relevant for: drug discovery groups doing property prediction or virtual screening, protein engineering groups who need sequence embeddings for downstream ML, and computational biology labs starting to work with large protein language models.
Pricing
Freemium. NVIDIA provides API access with free trial credits. Extended use of the cloud API is paid. The BioNeMo Framework (for local deployment) is open-source under Apache 2.0 — free to use with your own compute.
Strengths
- Provides production-ready implementations of key biomolecular models that would take significant engineering effort to set up independently
- Fine-tuning support: adapt pre-trained models to your specific task (predict binding affinity for your protein class, generate molecules with specific properties) without starting from scratch
- GPU-optimized — models are designed to run efficiently on NVIDIA hardware, which matters for throughput at scale
- Open-source framework option for groups who want to control their own compute and data without going through a cloud API
Limitations
- Designed around NVIDIA GPU infrastructure — less straightforward on AMD or CPU-only setups
- The cloud API suits exploration; serious production-scale use requires either significant API budget or investment in your own GPU cluster
- BioNeMo wraps other models (ESM-2, AlphaFold, DiffDock); understanding the limitations of each underlying model matters as much as understanding BioNeMo itself
- Biomolecular AI is moving fast — verify which model versions are currently available and whether newer versions of key models (e.g., ESM-3) have been integrated
How it compares
| vs. | Key difference |
|---|---|
| AlphaFold (standalone) | AlphaFold standalone gives you one task (structure prediction); BioNeMo combines structure prediction with language model embeddings, molecular generation, and docking in one platform |
| Hugging Face (ESM-2, etc.) | Many of the same models are available on Hugging Face; BioNeMo adds GPU-optimized training workflows and fine-tuning infrastructure on top |
| Schrödinger / MOE | Commercial structural biology platforms with broader functionality but proprietary; BioNeMo is open-source-friendly and skews toward ML-based rather than physics-based approaches |
Related content
- Field Guide: Health & Medicine
- Tool: AlphaFold
- Glossary: Virtual Screening